Cis-Acting Regulation of Brain-Specific ANK3 Gene Expression by a Genetic Variant Associated with Bipolar Disorder
Rueckert, Erroll H.
Bergen, Sarah E.
Luce, Catherine J.
Sheridan, Steven D.
Theriault, Kraig M.
Sklar, PamelaNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationRueckert, E. H., D. Barker, D. Ruderfer, S. E. Bergen, C. O’Dushlaine, C. J. Luce, S. D. Sheridan, et al. 2013. “Cis-Acting Regulation of Brain-Specific ANK3 Gene Expression by a Genetic Variant Associated with Bipolar Disorder.” Molecular psychiatry 18 (8): 10.1038/mp.2012.104. doi:10.1038/mp.2012.104. http://dx.doi.org/10.1038/mp.2012.104.
AbstractSeveral genome-wide association studies (GWAS) for bipolar disorder (BD) have found a strong association of the Ankyrin3 (ANK3) gene. This association spans numerous linked single nucleotide polymorphisms (SNPs) in a ~250 kb genomic region overlapping ANK3. The associated region encompasses predicted regulatory elements as well as two of six validated alternative first exons, which encode distinct protein domains at the N-terminus of the protein also known as ankyrin-G (AnkG). Using RNA Ligase-Mediated Rapid Amplification of cDNA Ends (RLM-RACE) to identify novel transcripts in conjunction with a highly sensitive, exon-specific multiplexed mRNA expression assay, we detected differential regulation of distinct ANK3 transcription start sites (TSSs) and coupling of specific 5’ ends with 3’ mRNA splicing events in post-mortem human brain and human stem cell-derived neural progenitors and neurons. Furthermore, allelic variation at the BD–associated SNP rs1938526 correlated with a significant difference in cerebellar expression of a brain-specific ANK3 transcript. These findings suggest a brain-specific cis-regulatory transcriptional effect of ANK3 may be relevant to BD pathophysiology.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:11879743